Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 Aug;118(7):1790–1796. doi: 10.1111/j.1476-5381.1996.tb15605.x

Direct chronotropic effects of atrial and C-type natriuretic peptides in anaesthetized dogs.

P Beaulieu 1, R Cardinal 1, A De Léan 1, C Lambert 1
PMCID: PMC1909842  PMID: 8842445

Abstract

1. The chronotropic effects of atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP) were investigated using injections (50 micrograms in 1 ml of Tyrode solution as bolus over 1 min) directly into the sinus node artery of 21 anaesthetized and vagotomized dogs which had been pretreated with a beta-adrenoceptor antagonist. The injections were also repeated following: (a) alpha-adrenoceptor antagonism (prazosin) and muscarinic receptor antagonism (atropine); (b) inhibition of prostaglandin synthesis (indomethacin); (c) angiotensin II AT1 receptor antagonism (losartan); (d) histamine H1 (mepyramine) and H2 (cimetidine) receptor antagonism. 2. The results obtained indicate that ANP had no significant effect on the basal sinus rate, whereas CNP produced a slight but significant increase of 12 +/- 2 beats min-1. The effect of CNP was long-lasting (return to pre-injection levels after maximum effect in 17 +/- 3 min) and was not influenced by the various antagonists mentioned above. 3. During in vitro experiments on spontaneously beating right atria isolated from 6 dogs, the injection of CNP (50 micrograms in 1 ml of Tyrode solution) into the sinus node artery produced an increase in atrial rate of 14 +/- 1 beats min-1. 4. The results of this work indicate that CNP exerts a significant and prolonged positive chronotropic effect both in vivo and in vitro. Other studies are required to elucidate the mechanism of action of CNP on the heart conduction system, to ascertain the presence of natriuretic peptide receptor B in the region of the sinoatrial node and to determine the role of CNP in the control of heart rate.

Full text

PDF
1790

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ackermann U., Khanna J., Irizawa T. G. Atrial natriuretic factor alters autonomic interactions in the control of heart rate in conscious rats. Can J Physiol Pharmacol. 1988 Jul;66(7):930–936. doi: 10.1139/y88-151. [DOI] [PubMed] [Google Scholar]
  2. Atchison D. J., Ackermann U. Influence of atrial natriuretic factor on autonomic control of heart rate. Am J Physiol. 1990 Mar;258(3 Pt 2):R718–R723. doi: 10.1152/ajpregu.1990.258.3.R718. [DOI] [PubMed] [Google Scholar]
  3. Atchison D. J., Ackermann U. The interaction between atrial natriuretic peptide and cardiac parasympathetic function. J Auton Nerv Syst. 1993 Jan;42(1):81–88. doi: 10.1016/0165-1838(93)90344-t. [DOI] [PubMed] [Google Scholar]
  4. Atchison D. J., Pennefather P. S., Ackermann U. ANP has no postsynaptic effect on autonomic regulation of cardiac pacemaker rate in the rat. Am J Physiol. 1993 Dec;265(6 Pt 2):H1983–H1987. doi: 10.1152/ajpheart.1993.265.6.H1983. [DOI] [PubMed] [Google Scholar]
  5. Baum T., Sybertz E. J., Watkins R. W., Nelson S., Coleman W., Pula K. K., Prioli N., Rivelli M., Grossman A. Hemodynamic actions of a synthetic atrial natriuretic factor. J Cardiovasc Pharmacol. 1986 Sep-Oct;8(5):898–905. doi: 10.1097/00005344-198609000-00003. [DOI] [PubMed] [Google Scholar]
  6. Bie P., Wang B. C., Leadley R. J., Jr, Goetz K. L. Hemodynamic and renal effects of low-dose infusions of atrial peptide in awake dogs. Am J Physiol. 1988 Feb;254(2 Pt 2):R161–R169. doi: 10.1152/ajpregu.1988.254.2.R161. [DOI] [PubMed] [Google Scholar]
  7. Brown L. A., Nunez D. J., Wilkins M. R. Differential regulation of natriuretic peptide receptor messenger RNAs during the development of cardiac hypertrophy in the rat. J Clin Invest. 1993 Dec;92(6):2702–2712. doi: 10.1172/JCI116887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cantin M., Thibault G., Haile-Meskel H., Ding J., Milne R. W., Ballak M., Charbonneau C., Nemer M., Drouin J., Garcia R. Atrial natriuretic factor in the impulse-conduction system of rat cardiac ventricles. Cell Tissue Res. 1989;256(2):309–325. doi: 10.1007/BF00218888. [DOI] [PubMed] [Google Scholar]
  9. Cargill R. I., Coutie W. J., Lipworth B. J. The effects of angiotensin II on circulating levels of natriuretic peptides. Br J Clin Pharmacol. 1994 Aug;38(2):139–142. doi: 10.1111/j.1365-2125.1994.tb04337.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Charles C. J., Espiner E. A., Richards A. M., Donald R. A. Central C-type natriuretic peptide augments the hormone response to hemorrhage in conscious sheep. Peptides. 1995;16(1):129–132. doi: 10.1016/0196-9781(94)00160-8. [DOI] [PubMed] [Google Scholar]
  11. Chrisman T. D., Schulz S., Potter L. R., Garbers D. L. Seminal plasma factors that cause large elevations in cellular cyclic GMP are C-type natriuretic peptides. J Biol Chem. 1993 Feb 15;268(5):3698–3703. [PubMed] [Google Scholar]
  12. Clavell A. L., Stingo A. J., Wei C. M., Heublein D. M., Burnett J. C., Jr C-type natriuretic peptide: a selective cardiovascular peptide. Am J Physiol. 1993 Feb;264(2 Pt 2):R290–R295. doi: 10.1152/ajpregu.1993.264.2.R290. [DOI] [PubMed] [Google Scholar]
  13. Ebert T. J., Cowley A. W., Jr Atrial natriuretic factor attenuates carotid baroreflex-mediated cardioacceleration in humans. Am J Physiol. 1988 Apr;254(4 Pt 2):R590–R594. doi: 10.1152/ajpregu.1988.254.4.R590. [DOI] [PubMed] [Google Scholar]
  14. Espiner E. A. Physiology of natriuretic peptides. J Intern Med. 1994 Jun;235(6):527–541. doi: 10.1111/j.1365-2796.1994.tb01261.x. [DOI] [PubMed] [Google Scholar]
  15. Franco-Saenz R., Somani P., Mulrow P. J. Effect of atrial natriuretic peptide (8-33-Met ANP) in patients with hypertension. Am J Hypertens. 1992 May;5(5 Pt 1):266–275. doi: 10.1093/ajh/5.5.266. [DOI] [PubMed] [Google Scholar]
  16. Gisbert M. P., Fischmeister R. Atrial natriuretic factor regulates the calcium current in frog isolated cardiac cells. Circ Res. 1988 Apr;62(4):660–667. doi: 10.1161/01.res.62.4.660. [DOI] [PubMed] [Google Scholar]
  17. Goetz K. L., Wang B. C., Geer P. G., Sundet W. D., Needleman P. Effects of atriopeptin infusion versus effects of left atrial stretch in awake dogs. Am J Physiol. 1986 Feb;250(2 Pt 2):R221–R226. doi: 10.1152/ajpregu.1986.250.2.R221. [DOI] [PubMed] [Google Scholar]
  18. Hageman G. R., Urthaler F., Isobe J. H., James T. N. Chronotropic and dromotropic effects of histamine on the canine heart. Chest. 1979 May;75(5):597–604. doi: 10.1378/chest.75.5.597. [DOI] [PubMed] [Google Scholar]
  19. Henning R. J. Vagal stimulation during muscarinic and beta-adrenergic blockade increases atrial contractility and heart rate. J Auton Nerv Syst. 1992 Sep;40(2):121–129. doi: 10.1016/0165-1838(92)90023-a. [DOI] [PubMed] [Google Scholar]
  20. Heublein D. M., Clavell A. L., Stingo A. J., Lerman A., Wold L., Burnett J. C., Jr C-type natriuretic peptide immunoreactivity in human breast vascular endothelial cells. Peptides. 1992 Sep-Oct;13(5):1017–1019. doi: 10.1016/0196-9781(92)90065-b. [DOI] [PubMed] [Google Scholar]
  21. Hiwatari M., Satoh K., Angus J. A., Johnston C. I. No effect of atrial natriuretic factor on cardiac rate, force and transmitter release. Clin Exp Pharmacol Physiol. 1986 Feb;13(2):163–168. doi: 10.1111/j.1440-1681.1986.tb00331.x. [DOI] [PubMed] [Google Scholar]
  22. Hunt P. J., Richards A. M., Espiner E. A., Nicholls M. G., Yandle T. G. Bioactivity and metabolism of C-type natriuretic peptide in normal man. J Clin Endocrinol Metab. 1994 Jun;78(6):1428–1435. doi: 10.1210/jcem.78.6.8200946. [DOI] [PubMed] [Google Scholar]
  23. Imaizumi T., Takeshita A. Influence of ANP on sympathetic nerve activity and chronotropic regulation of the heart. J Cardiovasc Electrophysiol. 1993 Dec;4(6):719–729. doi: 10.1111/j.1540-8167.1993.tb01257.x. [DOI] [PubMed] [Google Scholar]
  24. JAMES T. N., NADEAU R. A. Direct perfusion of the sinus node: an experimental model for pharmacologic and electrophysiologic studies of the heart. Henry Ford Hosp Med Bull. 1962 Mar;10:21–25. [PubMed] [Google Scholar]
  25. Komatsu Y., Nakao K., Itoh H., Suga S., Ogawa Y., Imura H. Vascular natriuretic peptide. Lancet. 1992 Sep 5;340(8819):622–622. doi: 10.1016/0140-6736(92)92167-e. [DOI] [PubMed] [Google Scholar]
  26. Lambert C. Mechanisms of angiotensin II chronotropic effect in anaesthetized dogs. Br J Pharmacol. 1995 Jul;115(5):795–800. doi: 10.1111/j.1476-5381.1995.tb15003.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Lambert C., Ribuot C., Robichaud A., Cusson J. R. Negative chronotropic effect of the atrial natriuretic peptide in an anesthetized dog model. Eur J Pharmacol. 1994 Feb 11;252(3):245–252. doi: 10.1016/0014-2999(94)90169-4. [DOI] [PubMed] [Google Scholar]
  28. Murad F., Rapoport R. M., Fiscus R. Role of cyclic-GMP in relaxations of vascular smooth muscle. J Cardiovasc Pharmacol. 1985;7 (Suppl 3):S111–S118. [PubMed] [Google Scholar]
  29. Nunez D. J., Dickson M. C., Brown M. J. Natriuretic peptide receptor mRNAs in the rat and human heart. J Clin Invest. 1992 Nov;90(5):1966–1971. doi: 10.1172/JCI116075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Osterode W., Nowotny P., Vierhapper H., Waldhäusl W. Kinetics of plasma cyclic GMP and atrial natriuretic peptide after intravenous, intramuscular and subcutaneous injection of 50 micrograms hANP in man. Horm Metab Res. 1995 Feb;27(2):100–103. doi: 10.1055/s-2007-979917. [DOI] [PubMed] [Google Scholar]
  31. Ribuot C., Godin D., Couture R., Regoli D., Nadeau R. In vivo B2-receptor-mediated negative chronotropic effect of bradykinin in canine sinus node. Am J Physiol. 1993 Sep;265(3 Pt 2):H876–H879. doi: 10.1152/ajpheart.1993.265.3.H876. [DOI] [PubMed] [Google Scholar]
  32. Rigel D. F. Effects of neuropeptides on heart rate in dogs: comparison of VIP, PHI, NPY, CGRP, and NT. Am J Physiol. 1988 Aug;255(2 Pt 2):H311–H317. doi: 10.1152/ajpheart.1988.255.2.H311. [DOI] [PubMed] [Google Scholar]
  33. Rowe G. G., Henderson R. H. Systemic and coronary hemodynamic effects of sodium nitroprusside. Am Heart J. 1974 Jan;87(1):83–87. doi: 10.1016/0002-8703(74)90394-9. [DOI] [PubMed] [Google Scholar]
  34. Saito A., Kimura S., Goto K. Calcitonin gene-related peptide as potential neurotransmitter in guinea pig right atrium. Am J Physiol. 1986 Apr;250(4 Pt 2):H693–H698. doi: 10.1152/ajpheart.1986.250.4.H693. [DOI] [PubMed] [Google Scholar]
  35. Sasaki A., Kida O., Kangawa K., Matsuo H., Tanaka K. Involvement of sympathetic nerves in cardiosuppressive effects of alpha-human atrial natriuretic polypeptide (alpha-hANP) in anesthetized rats. Eur J Pharmacol. 1986 Jan 29;120(3):345–349. doi: 10.1016/0014-2999(86)90475-9. [DOI] [PubMed] [Google Scholar]
  36. Stanaszek W. F., Kellerman D., Brogden R. N., Romankiewicz J. A. Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure. Drugs. 1983 Apr;25(4):339–384. doi: 10.2165/00003495-198325040-00002. [DOI] [PubMed] [Google Scholar]
  37. Stingo A. J., Clavell A. L., Aarhus L. L., Burnett J. C., Jr Cardiovascular and renal actions of C-type natriuretic peptide. Am J Physiol. 1992 Jan;262(1 Pt 2):H308–H312. doi: 10.1152/ajpheart.1992.262.1.H308. [DOI] [PubMed] [Google Scholar]
  38. Sudoh T., Minamino N., Kangawa K., Matsuo H. C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun. 1990 Apr 30;168(2):863–870. doi: 10.1016/0006-291x(90)92401-k. [DOI] [PubMed] [Google Scholar]
  39. Suga S., Nakao K., Hosoda K., Mukoyama M., Ogawa Y., Shirakami G., Arai H., Saito Y., Kambayashi Y., Inouye K. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology. 1992 Jan;130(1):229–239. doi: 10.1210/endo.130.1.1309330. [DOI] [PubMed] [Google Scholar]
  40. Terzic A., Pucéat M., Vassort G., Vogel S. M. Cardiac alpha 1-adrenoceptors: an overview. Pharmacol Rev. 1993 Jun;45(2):147–175. [PubMed] [Google Scholar]
  41. Trachte G. J., Kanwal S., Elmquist B. J., Ziegler R. J. C-type natriuretic peptide neuromodulates via "clearance" receptors. Am J Physiol. 1995 Apr;268(4 Pt 1):C978–C984. doi: 10.1152/ajpcell.1995.268.4.C978. [DOI] [PubMed] [Google Scholar]
  42. Tsutsui M., Yanagihara N., Minami K., Kobayashi H., Nakashima Y., Kuroiwa A., Izumi F. C-type natriuretic peptide stimulates catecholamine synthesis through the accumulation of cyclic GMP in cultured bovine adrenal medullary cells. J Pharmacol Exp Ther. 1994 Feb;268(2):584–589. [PubMed] [Google Scholar]
  43. Vollmar A. M., Gerbes A. L., Nemer M., Schulz R. Detection of C-type natriuretic peptide (CNP) transcript in the rat heart and immune organs. Endocrinology. 1993 Apr;132(4):1872–1874. doi: 10.1210/endo.132.4.8462485. [DOI] [PubMed] [Google Scholar]
  44. Wei C. M., Aarhus L. L., Miller V. M., Burnett J. C., Jr Action of C-type natriuretic peptide in isolated canine arteries and veins. Am J Physiol. 1993 Jan;264(1 Pt 2):H71–H73. doi: 10.1152/ajpheart.1993.264.1.H71. [DOI] [PubMed] [Google Scholar]
  45. Wei C. M., Hu S., Miller V. M., Burnett J. C., Jr Vascular actions of C-type natriuretic peptide in isolated porcine coronary arteries and coronary vascular smooth muscle cells. Biochem Biophys Res Commun. 1994 Nov 30;205(1):765–771. doi: 10.1006/bbrc.1994.2731. [DOI] [PubMed] [Google Scholar]
  46. Woods W. T., Urthaler F., James T. N. Spontaneous action potentials of cells in the canine sinus node. Circ Res. 1976 Jul;39(1):76–82. doi: 10.1161/01.res.39.1.76. [DOI] [PubMed] [Google Scholar]
  47. Zeuzem S., Olbrich H. G., Haak T., Jungmann E. In vivo evidence that human atrial natriuretic factor-(99-126) (hANF) stimulates parasympathetic activity in man. Eur J Clin Pharmacol. 1990;39(1):77–79. doi: 10.1007/BF02657063. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES